Company Filing History:
7 out of 277 
5 out of 622 
1 out of 62 Years Active: 2019-2023
Title: Inventor Cleoma Arnold: Innovating Polymerase Variants
Introduction
Cleoma Arnold, an accomplished inventor based in San Jose, CA, has made significant contributions to the field of biotechnology. With a remarkable portfolio of eight patents, Arnold's work primarily focuses on the development of advanced polymerase variants, which hold considerable promise for various applications.
Latest Patents
Among her notable patents, Arnold has described a variant pol6 polymerase characterized by a specific set of mutations. These mutations include H223, N224, Y225, H227, I295, Y342, T343, I357, S360, L361, I363, S365, S366, Y367, P368, D417, E475, Y476, F478, K518, H527, T529, M531, N535, G539, P542, N545, Q546, A547, L549, I550, N552, G553, F558, A596, G603, A610, V615, Y622, C623, D624, I628, Y629, R632, N635, M641, A643, I644, T647, I648, T651, I652, K655, W656, D657, V658, H660, F662, and L690, along with various combinations of these. This invention underscores her innovative approach in enhancing polymerase technology.
Career Highlights
Cleoma Arnold has built her career in the dynamic environment of biotechnology companies. Notably, she has worked with Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc., where she has engaged in cutting-edge research and development. Her expertise has played a crucial role in advancing molecular technologies that are instrumental in genetic research and diagnostics.
Collaborations
Throughout her career, Arnold has collaborated with esteemed colleagues, including Aruna Ayer and Charles Wayan Schwab. These partnerships have enabled her to leverage collective knowledge and expertise, driving the development of her innovative polymerase solutions.
Conclusion
Cleoma Arnold exemplifies the spirit of innovation in the biotechnology sector. Her work on polymerase variants not only contributes to scientific advancement but also has practical applications that could revolutionize genetic research. As she continues to push the boundaries of biotechnological inventions, her role as an inventor remains pivotal in shaping the future of molecular science.